Full-Time

Scrum Master

Precision Medicine

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Mid, Senior

Hyderabad, Telangana, India

Category
Project Management
Medical, Clinical & Veterinary
Business & Strategy
Required Skills
Agile
Word/Pages/Docs
JIRA
SCRUM
Excel/Numbers/Sheets
Requirements
  • Master’s degree with 4 - 6 years of experience in Computer Science, IT or related field OR
  • Bachelor’s degree with 6 - 8 years of experience in Computer Science, IT or related field
  • Diploma degree with 10-12 years of experience in Computer Science, IT or related field
  • 5+ years’ Delivery Manager or Project Management experience
  • 2+ years’ experience working in a highly agile (SAFe, Scrum, Kanban) environment
  • Experience with ITIL and Service Management
  • Experience operating within a validated systems environment (FDA, European Agency for the Evaluation of Medicinal Products, Ministry of Health, etc.)
  • Experience working cross-functionally and building collaborative working relationships; interfacing effectively with stakeholders, operations and management to resolve issues
  • Ability to organize and schedule tasks, develop realistic action plans incorporating time constraints and task priorities
  • Previous experience working in a highly collaborative and culturally diverse environment
  • Excellent Microsoft Teams, Excel, Word, and PowerPoint skills
  • Jira experience
  • SAFe training experience
Responsibilities
  • Bring experience, expertise, and creativity to the creation of standards for use of Jira, handoffs, and roles and responsibilities across the Agile Team.
  • Facilitate team events such as Daily Stand-ups, Iteration Planning, reviews, and retrospectives
  • Proactively monitor samples of work Act as a servant leader and coach for and within Product and Platform teams
  • Foster an environment where the team can stay focused
  • Educate the team about Lean and Agile practices like Scrum
  • Proactively listen for challenges, gaps, and blockers, and guide the team to actions to remove roadblocks and impediments
  • Support the Product Owner in managing the backlog and guiding the team
  • Strengthen communication and relationships with other teams, especially those on the Agile Release Train (ART)
  • Track team metrics and find ways to improve team performance
  • Continuously learn and improve as a Scrum Master to better support the team's success, including participation in Amgen Communities of Practice
Desired Qualifications
  • Workshop facilitation experience
  • Slido or other survey building experience
  • Certified SAFe 6 Agilist (preferred)
  • Certified SAFe 6 Practitioner - (preferred)
  • Certified SAFe 6 Release Train Engineer (preferred)
  • ITIL 4 Foundations (preferred)

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.